A phase 2 efficacy and safety study of SU011248 [sunitinib] in patients with non-small cell lung cancer and brain metastases
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2007
At a glance
- Drugs Sunitinib (Primary)
- Indications Cancer metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Apr 2007 New trial record.